Cancer Genetics Announces Launch of CALR Mutation Analysis Test to Assist in Diagnosis of Acute Leukemias & Myeloproliferative Neoplasms

[GlobeNewswire] – RUTHERFORD, N.J. — Cancer Genetics, Inc. (CGI or the Company), an emerging leader in DNA-based cancer diagnostics, has launched a genetic diagnostic test for detecting mutations … more

View todays social media effects on CGIX

View the latest stocks trending across Twitter. Click to view dashboard

See who Cancer is hiring next, click here to view